For ob/gyns who are seeking concrete steps to incorporate the newest evidence into practice, refer to these easy steps.
©s_l - adobe.stock_.com
For ob/gyns who are seeking concrete steps to incorporate the newest evidence into practice, refer to these easy steps and to 'Mifepristone and misoprostol: Medical management of missed abortion' for access to the required forms.
SIGN UP: Complete Prescriber Agreement and Account Setup Form
ORDER: Once registered, you may order the medication to be stocked in the office.
The Patient and Agreement and the Medication Guide are:
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More